<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326842</url>
  </required_header>
  <id_info>
    <org_study_id>HZHZS1</org_study_id>
    <nct_id>NCT04326842</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis</brief_title>
  <official_title>Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Harbin Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate ocular changes in patients with carotid artery stenosis by&#xD;
      optical coherence tomography angiography before and after carotid artery revascularization&#xD;
      procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A growing body of research indicates that abnormal ocular microvascular features may serve as&#xD;
      a novel biomarker reflecting the severity of underlying cardiovascular, neurodegenerative,&#xD;
      and microvascular disease. Since blood flow to the retina is predominantly supplied by the&#xD;
      internal carotid artery (ICA), we hypothesized that ocular microvasculature and structure&#xD;
      changes may reflect the disease status or therapeutic effects in patients with carotid artery&#xD;
      stenosis.&#xD;
&#xD;
      Optical coherence tomography angiography (OCTA) is a novel, non-invasive imaging modality&#xD;
      that can be a reliable tool for the qualitative and quantitative assessments of ocular&#xD;
      vessels during various ocular pathological or physiological changes. Recent studies have also&#xD;
      demonstrated the ability of OCTA to quantify retinal microvascular changes in monitoring&#xD;
      cardiovascular risk.&#xD;
&#xD;
      This study aims to evaluate ocular changes in patients with carotid artery stenosis by&#xD;
      optical coherence tomography angiography before and after carotid artery revascularization&#xD;
      procedure.In this study, the patients with carotid artery stenosis and control group will&#xD;
      receive a series of cerebral and ocular examinations including the most important cerebral CT&#xD;
      perfusion (CTP) and OCTA. After that, the cerebral and ocular data between the two groups&#xD;
      will be compared. Also, the preoperative and postoperative data acquired will be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2020</start_date>
  <completion_date type="Actual">July 2, 2020</completion_date>
  <primary_completion_date type="Actual">June 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Radical Peripapillary Capillaries Vessel Density</measure>
    <time_frame>Difference of vessel density in each group at baseline</time_frame>
    <description>Radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography（OCTA）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Superficial Vascular Complexes Vessel Density</measure>
    <time_frame>Difference of vessel density in each group at baseline</time_frame>
    <description>superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Deep Vascular Complexes Vessel Density</measure>
    <time_frame>Difference of vessel density in each group at baseline</time_frame>
    <description>deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Choriocapillaris Vessel Density</measure>
    <time_frame>Difference of vessel density in each group at baseline</time_frame>
    <description>choriocapillaris vessel density of Optical Coherence Tomography Angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Difference of Mean Transit Time(dMTT)</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>Change of dMTT is the dMTT value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
dMTT is that the value of the lesion side minus value of contralateral side. Mean transit time (MTT) corresponds to the average time, in seconds, that red blood cells spend within a determinate volume of capillary circulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the Ratio of Cerebral Blood Flow(rCBF)</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>Change of rCBF is the rCBF value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
rCBF is that the CBF value of the lesion side divided by the value of contralateral side.&#xD;
CBF refers to the flow of blood through a certain cross-sectional area of cerebrovascular per unit time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Retinal Nerve Fiber Layer</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>changes of retinal nerve fiber layer of Optical Coherence Tomography Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Deep Vascular Complexes Vessel Density</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>changes of deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Radical Peripapillary Capillaries Vessel Density</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>changes of radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of Superficial Vascular Complexes Vessel Density</measure>
    <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
    <description>changes of superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">129</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
    <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients without carotid artery stenosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid artery revascularization procedure</intervention_name>
    <description>The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.</description>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherence tomography angiography</intervention_name>
    <description>Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
    <arm_group_label>Carotid artery stenosis</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with carotid artery stenosis undergoing cerebral and eye examination and in&#xD;
        routine clinical practice will be included&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of carotid artery stenosis&#xD;
&#xD;
          -  Age-gender-race-matched controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;18 years&#xD;
&#xD;
          -  intraocular pressure (IOP) &gt;21 mmHg&#xD;
&#xD;
          -  VA &gt;logMAR 1.0&#xD;
&#xD;
          -  spherical equivalent (SE) between &gt;1.00 or &lt; -6.00 D&#xD;
&#xD;
          -  other serious eye diseases which may affect OCTA results including diabetic&#xD;
             retinopathy, hypertensive retinopathy, retinal vascular occlusion, age-related macular&#xD;
             degeneration, and uveitis&#xD;
&#xD;
          -  major intraocular surgery performed in the past 6 months or a history of laser&#xD;
             photocoagulation or intravitreal injection&#xD;
&#xD;
          -  glaucoma or first-degree relatives with a history of glaucoma; and&#xD;
&#xD;
          -  any disease that might cause poor scan quality (image quality &lt;6).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huaizhang Shi</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <results_first_submitted>July 6, 2020</results_first_submitted>
  <results_first_submitted_qc>September 23, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 19, 2020</results_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carotid Stenosis</keyword>
  <keyword>OCTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT04326842/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 5, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT04326842/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Carotid Artery Stenosis</title>
          <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Carotid Artery Stenosis</title>
          <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.68" spread="6.82"/>
                    <measurement group_id="B2" value="55.39" spread="11.01"/>
                    <measurement group_id="B3" value="59.04" spread="8.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alcohol</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="31"/>
                    <count group_id="B2" value="31"/>
                    <count group_id="B3" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Radical Peripapillary Capillaries Vessel Density</title>
        <description>Radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography（OCTA）</description>
        <time_frame>Difference of vessel density in each group at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Radical Peripapillary Capillaries Vessel Density</title>
          <description>Radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography（OCTA）</description>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.95" lower_limit="53.30" upper_limit="58.10"/>
                    <measurement group_id="O2" value="57.24" lower_limit="56.00" upper_limit="59.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Superficial Vascular Complexes Vessel Density</title>
        <description>superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>Difference of vessel density in each group at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Superficial Vascular Complexes Vessel Density</title>
          <description>superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.65" lower_limit="45.50" upper_limit="51.10"/>
                    <measurement group_id="O2" value="52.22" lower_limit="50.14" upper_limit="52.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Deep Vascular Complexes Vessel Density</title>
        <description>deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>Difference of vessel density in each group at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Deep Vascular Complexes Vessel Density</title>
          <description>deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.65" lower_limit="46.50" upper_limit="53.70"/>
                    <measurement group_id="O2" value="57.50" lower_limit="53.80" upper_limit="59.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Choriocapillaris Vessel Density</title>
        <description>choriocapillaris vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>Difference of vessel density in each group at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients without carotid artery stenosis&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Choriocapillaris Vessel Density</title>
          <description>choriocapillaris vessel density of Optical Coherence Tomography Angiography</description>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.41" lower_limit="62.90" upper_limit="69.92"/>
                    <measurement group_id="O2" value="68.74" lower_limit="65.91" upper_limit="71.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Difference of Mean Transit Time(dMTT)</title>
        <description>Change of dMTT is the dMTT value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
dMTT is that the value of the lesion side minus value of contralateral side. Mean transit time (MTT) corresponds to the average time, in seconds, that red blood cells spend within a determinate volume of capillary circulation.</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Difference of Mean Transit Time(dMTT)</title>
          <description>Change of dMTT is the dMTT value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
dMTT is that the value of the lesion side minus value of contralateral side. Mean transit time (MTT) corresponds to the average time, in seconds, that red blood cells spend within a determinate volume of capillary circulation.</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" lower_limit="-0.46" upper_limit="-0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of the Ratio of Cerebral Blood Flow(rCBF)</title>
        <description>Change of rCBF is the rCBF value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
rCBF is that the CBF value of the lesion side divided by the value of contralateral side.&#xD;
CBF refers to the flow of blood through a certain cross-sectional area of cerebrovascular per unit time.</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of the Ratio of Cerebral Blood Flow(rCBF)</title>
          <description>Change of rCBF is the rCBF value at 4 days after carotid artery procedure minus the value at baseline.&#xD;
rCBF is that the CBF value of the lesion side divided by the value of contralateral side.&#xD;
CBF refers to the flow of blood through a certain cross-sectional area of cerebrovascular per unit time.</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" lower_limit="0.02" upper_limit="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Retinal Nerve Fiber Layer</title>
        <description>changes of retinal nerve fiber layer of Optical Coherence Tomography Angiography</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Retinal Nerve Fiber Layer</title>
          <description>changes of retinal nerve fiber layer of Optical Coherence Tomography Angiography</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>μm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.50" lower_limit="2.00" upper_limit="11.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Deep Vascular Complexes Vessel Density</title>
        <description>changes of deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Deep Vascular Complexes Vessel Density</title>
          <description>changes of deep vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.00" lower_limit="0.70" upper_limit="6.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Radical Peripapillary Capillaries Vessel Density</title>
        <description>changes of radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Radical Peripapillary Capillaries Vessel Density</title>
          <description>changes of radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.55" lower_limit="0.40" upper_limit="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of Superficial Vascular Complexes Vessel Density</title>
        <description>changes of superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
        <time_frame>baseline and 4 days after carotid artery procedure</time_frame>
        <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Artery Stenosis</title>
            <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of Superficial Vascular Complexes Vessel Density</title>
          <description>changes of superficial vascular complexes vessel density of Optical Coherence Tomography Angiography</description>
          <population>This Outcome Measure was only assessed in the &quot;Carotid Artery Stenosis&quot; Arm/Group Among the 31 patients in the experimental group, 21 patients had unilateral severe stenosis or occlusion and 7 patients dropped out of the study</population>
          <units>percentage of vessel</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.70" lower_limit="0.40" upper_limit="2.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2weeks post-operation</time_frame>
      <desc>A patient developed cerebral infarction 7 days after operation, which resulted in prolongation of existing hospitalization.</desc>
      <group_list>
        <group group_id="E1">
          <title>Carotid Artery Stenosis</title>
          <description>Patients with carotid artery stenosis. Procedure: Carotid artery revascularization procedure&#xD;
Carotid artery revascularization procedure: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.&#xD;
Optical coherence tomography angiography: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patients without carotid artery stenosis. Examination will be performed using optical coherence tomography angiography. Control group did not undergo carotid artery surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Hong Zhang</name_or_title>
      <organization>The First Affiliated Hospital of Harbin Medical University</organization>
      <phone>+86 0451-85553952</phone>
      <email>2315186458@qq.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

